NewsBenzingaチャーダン・キャピタルはCamp4 Therapeuticsの「買い」評価を維持、目標株価を6ドルに引き下げ チャーダン・キャピタルはCamp4 Therapeuticsの「買い」評価を維持、目標株価を6ドルに引き下げ Benzinga 2026.09.29 12:11 (GMT+0) Open on Benzinga Other news Stocks Rebound as Crude Prices Fall and Bond Yields Stabilize How Investors Should View Marvell Stock as Seaport Analysts Join the MRVL Bulls What's Going On With Rocket Lab Stock Tuesday? HC Wainwright & Co. Reiterates Buy on Plug Power, Maintains $7 Price Target 'Stellantis To Suspend Production At Three French Plants' - Les Echos Craig-Hallum Maintains Buy on Boot Barn Holdings, Lowers Price Target to $224
